![Mitchell Goldman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Mitchell Goldman worked as the Vice President-Late Stage Biologics at AstraZeneca PLC from 2017 to 2020.
Prior to that, he was the Chief Medical Officer at Amicus Therapeutics, Inc. Dr. Goldman holds a doctorate degree from Case Western Reserve University and an undergraduate degree from The University of Colorado.
Former positions of Mitchell Goldman
| Companies | Position | End |
|---|---|---|
| ASTRAZENECA PLC | Corporate Officer/Principal | 2019-12-31 |
| AMICUS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Mitchell Goldman
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
74
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Amicus Therapeutics, Inc.
 Amicus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines for rare diseases | Health Technology |
Case Western Reserve University
 Case Western Reserve University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Colorado
 The University of Colorado Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Mitchell Goldman
Choose MarketScreener 
